Sonya Collins

Sonya Collins

Health Writer

Sonya Collins is an Atlanta-based independent journalist and editor. She covers health, medicine and scientific research, with a special emphasis on genetics and personalized medicine. Sonya is a regular contributor toWebMD Magazine, WebMD.com,CURE, andStaying Sharp. She is a contributing editor atThe Conversationand WebMD.com.

Latest Articles by Sonya Collins

JIA
Arthritis & Joints

Do Antibiotics Raise Your Child’s Risk of JIA?

Everything you need to know about a possible connection between these meds and juvenile idiopathic arthritis.

Man with pain in his hand
Rheumatoid Arthritis

A Multicultural Guide to Managing RA

When it comes to rheumatoid arthritis, the condition may be equally common across races but that’s where many of the similarities end. HealthCentral dives into the diverse experiences of the condition based on race, ethnicity, and culture.

supplements
更年期

What the Science Says About Menopausal Supplements

When estrogen wanes, hot flashes and night sweats can kick in—with few proven remedies. Here’s what’s may work.

heart attack
Heart Health

Why Are Women’s Heart Attack Symptoms Overlooked?

Gender differences in warning signs mean women are often misdiagnosed, despite heart disease being their number-one killer.

melatonin
更年期

Is Melatonin Mighty for Menopause?

Improved sleep, better mood, stronger bones, plus less intense hot flashes and night sweats—what else could an aging woman want?

community meeting
Dementia

Dementia Training Bootcamp for Caregivers: What to Expect

From learning about the disease to gaining support from others, these programs (kindly) put you through your paces.

senior eyes
Dementia

Treating Adults With Dementia-Related Psychosis

Hallucinations and delusions can be deeply unsettling—for you and your loved one. Here’s how to manage them.

经颅磁年代timulation
Bipolar Disorder

Coming Soon! Help for Treatment-Resistant Bipolar Depression

Previously approved for major depression, transcranial magnetic stimulation is on the FDA fast track for bringing relief to people with treatment-resistant bipolar depression, too.